Hong Kong — EuroEyes International Eye Clinic Limited, an established ophthalmology brand, has appointed international communications consultancy Hume Brophy as its investor and public relations partner. The appointment aims to enhance awareness of EuroEyes’ distinct vision care offerings and its strong business and financial success as the company continues to rapidly expand globally.

Dr Jørn Slot Jørgensen, founder, chairman and CEO of EuroEyes, said, “Since establishing in 1993 and trading on the Hong Kong Stock Exchange in 2019, we have successfully executed our growth strategy, remained committed to expanding our clinics and services to clients, and continued to capitalise on business opportunities.”

Jørgensen added, “With our continued global expansion, we are now entering a new phase of growth. By partnering with an international communications firm like Hume Brophy, we look to optimise our brand exposure to the broader capital markets community in Hong Kong and beyond, enabling investors to better understand the potential investment value that EuroEyes offer and be part of our growth journey.”

A strategic communications programme will be put in place to increase the number of EuroEyes touchpoints with clients and investors, ensuring proper delivery of the latest and most relevant information about vision correction, business developments, and financial performances at EuroEyes.

Meanwhile, Thomas Kwan, director of Hume Brophy Communications Hong Kong, commented, “We are pleased to become the communications partner of EuroEyes. Our team of communications professionals will help potential clients and investors to better understand the advantages of EuroEyes – from both eye care and investment perspectives – and drive sustainable interactions that could translate to further business success for EuroEyes.”

Currently, the number of EuroEyes clinics around the world is close to 30. The company will continue to capitalise on the growing awareness of vision care, and identify new clinic locations or optimise existing surgical centres to better serve clients and achieve greater business results for shareholders.